The AUAUniversity podcast is an official podcast of the American Urological Association. More information can be found at https://auau.auanet.org
…
continue reading
1
AUA2024: Contemporary Pharmacotherapy for OAB 2024
2:06:14
2:06:14
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
2:06:14
AUA2024: Contemporary Pharmacotherapy for OAB 2024: Monotherapy and Combined Pharmacotherapy to Optimize TreatmentCME Available: https://auau.auanet.org/node/41048At the conclusion of this activity, participants will be able to:1. Define the similarities and differences between the various oral pharmacotherapies for overactive bladder (OAB)2. Revie…
…
continue reading
1
AUA2024: AUA Advanced Prostate Cancer Guidelines
2:05:07
2:05:07
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
2:05:07
AUA2024: AUA Advanced Prostate Cancer Guidelines CME Available: https://auau.auanet.org/node/41027At the conclusion of this activity, participants will be able to:1. Identify appropriate use of genetic testing and genetic counseling.2. Identify appropriate use of somatic testing and treatments related to specific genetic alterations.3. Identify app…
…
continue reading
1
Live from AUA2024: Highlights in Bladder Cancer
52:00
52:00
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
52:00
Live from AUA2024: Highlights in Bladder CancerCME Available: https://auau.auanet.org/node/41085At the conclusion of this activity, participants will be able to:1. Discuss the newly released amendment to the AUA/SUO Guideline on Non-Muscle Invasive Bladder Cancer.2. Describe recent developments in the management of non-muscle invasive bladder cance…
…
continue reading
1
AUA2024: Upper Tract Urothelial Carcinoma Tumor Board: A Case-Based Approach to Management
1:54:06
1:54:06
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
1:54:06
AUA2024: Upper Tract Urothelial Carcinoma Tumor Board: A Case-Based Approach to Management CME Available: https://auau.auanet.org/node/41040At the conclusion of this activity, participants will be able to:1. Identify clinically available data that can help assess risk of UTUC disease.2. Verbalize the important role of kidney function before and aft…
…
continue reading
1
AUA2024: Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider
1:56:16
1:56:16
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
1:56:16
AUA2024: Chemotherapy and Immunotherapy for the Urologist and Advanced Practice ProviderCME Available: https://auau.auanet.org/node/41048At the conclusion of this activity, participants will be able to:1. Define the similarities and differences between the various oral pharmacotherapies for overactive bladder (OAB)2. Review the principles of physio…
…
continue reading
1
AUA2024: Practical Implementation of Third-Line Therapies for Refractory Overactive Bladder
1:56:27
1:56:27
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
1:56:27
Practical Implementation of Third-Line Therapies for Refractory Overactive Bladder (OAB) Webcast (2024)CME Available: https://auau.auanet.org/node/41056At the conclusion of this activity, participants will be able to:1. Discuss the third-line therapies available to treat OAB refractory to conservative techniques.2. Effectively provide counseling re…
…
continue reading
1
AUA2024: Genetics and Genomics of Urological Cancers
2:01:29
2:01:29
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
2:01:29
AUA2024: 003IC Genetics and Genomics of Urological Cancers - Current Guidelines and Case-based Discussion to Guide Clinical PracticeCME Available: https://auau.auanet.org/node/40976At the conclusion of this activity, participants will be able to:1. Describe key components of genetic risk assessment, genetic counseling and informed consent for genet…
…
continue reading
Journal Club 101Guest: Melissa Kaufman, MD, PHD, FACSOutline:Segment #1: History of peer reviewSegment #2: Models of peer reviewSegment #3: General review best practicesSegment #4: General structure for manuscript reviewSegment #5: Granular aspects of manuscript reviewPar American Urological Association
…
continue reading
BPH: Surgical TreatmentGuest: Bilal Chughtai, MDOutline:Segment #1: Bladder HealthSegment #2: DiagnosticsSegment #3: StentsSegment #4: New MISTsPar American Urological Association
…
continue reading
1
AUA2024: Surgical Laser Enucleation of the Prostate
31:45
31:45
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
31:45
AUA2024: Surgical Laser Enucleation of the ProstateGuests: Amy Krambeck, MD and Mark Assmus, MDOutline:Segment #1: Why EnucleationSegment #2: What makes this course special?Segment #3: What is new this year compared to last year?Segment #4: What do you think makes this course unique?Segment #5: Who is the ideal participant?…
…
continue reading
1
AUA2024: A Specialized Masterclass for Single-port Robot-Assisted Surgery
31:15
31:15
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
31:15
AUA2024: A Specialized Masterclass for Single-port Robot-Assisted SurgeryGuests: Simone Crivellaro, MD and Ahmed Ghazi MD, MHPEOutline:Segment #1 Topic: The need for ongoing surgical education given the rise in introduction of new technologies in urology.Segment #2 Topic: Current status of Hands-on skills courses in UrologySegment #3 Topic: History…
…
continue reading
1
Update Series (2024) Lesson 1: A Case-Based Discussion of Priapism Guidelines
28:51
28:51
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
28:51
Update Series (2024) Lesson 1: A Case-Based Discussion of Priapism GuidelinesNow in its 43rd installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional…
…
continue reading
1
AUA2023 Take Home Messages Part 5
38:55
38:55
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
38:55
AUA2023 Take Home Messages Part 5Take Home Messages: Take Home Messages: BPH/LUTSSpeaker: Dr. Dean EltermanTake Home Messages: ImagingSpeaker: Dr. Richard MatulewiczTake Home Messages: Robotic SurgerySpeaker: Dr. Andrew HungTake Home Messages: Surgical EducationSpeaker: Dr. Simone ThavaseelanPar American Urological Association
…
continue reading
1
AUA2023 Take Home Messages Part 4
35:38
35:38
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
35:38
AUA2023 Take Home Messages Part 4Take Home Messages: Increasing Representation in UrologySpeaker: Dr Larissa BreslerTake Home Messages: Healthcare DisparitiesSpeaker: Dr. Adam MurphyTake Home Messages: TransplantationSpeaker: Dr. Jason LeeTake Home Messages: Female Urology/IncontinenceSpeaker: Dr. Yahir Santiago-Lastra…
…
continue reading
1
AUA2023 Take Home Messages Part 3
43:25
43:25
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
43:25
AUA2023 Take Home Messages Part 3Take Home Messages: Infertility/AndrologySpeaker: Dr. Joshua HalpernTake Home Messages: Sexual DysfunctionSpeaker: Dr. Peter TsambarlisTake Home Messages: PediatricsSpeaker: Dr. Kate KraftTake Home Messages: Global Health/HumanitarianSpeaker: Dr. Rajiv SingalPar American Urological Association
…
continue reading
1
AUA2023 Take Home Messages Part 2
38:28
38:28
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
38:28
AUA2023 Take Home Messages Part 2Take Home Messages: Basic Science (Benign)Speaker: Dr. Douglas StrandTake Home Messages: ReconstructionSpeaker: Dr. Jessica DeLongTake Home Messages: Endourology/StonesSpeaker: Dr. Noah CanvasserTake Home Messages: Infection/InflammationSpeaker: Dr. Chris DoironPar American Urological Association
…
continue reading
1
AUA2023 Take Home Messages Part 1
39:25
39:25
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
39:25
AUA2023 Take Home Messages Part 1Take Home Messages: Basic Science (Malignant)Speaker: Dr. Douglas ScherrTake Home Messages: Kidney CancerSpeaker: Dr. Amy LuckenbaughTake Home Messages: Bladder CancerSpeaker: Dr. Jennifer TaylorTake Home Messages: Prostate CancerSpeaker: Dr. Samuel WashingtonPar American Urological Association
…
continue reading
1
PARPi: Management of Adverse Events
53:34
53:34
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
53:34
PARPi: Management of Adverse Events (2024)CME Available: https://auau.auanet.org/node/39609Release Date: January, 2024Expiration Date: January, 2025LEARNING OBJECTIVES:1. Identify approved PARPi for prostate cancer and patients who may benefit from PARPi based therapy.2. Evaluate available clinical safety and efficacy data for PARPi.3. Describe ind…
…
continue reading
1
AUA2023 Journal of Urology Lecture
16:52
16:52
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
16:52
AUA2023 Journal of Urology Lecture: Surgery Harms Surgeons. What can we do?Speaker: Dr. Kevin TurnerPar American Urological Association
…
continue reading
1
AUA2023 Ramon Guiteras Lecture
21:00
21:00
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
21:00
AUA2023 Ramon Guiteras Lecture: The Complicated Decisions Required to Eliminate Never EventsSpeaker: Dr Louis Kavoussi, Smith Institute For Urology.Par American Urological Association
…
continue reading
1
AUA2023 John Duckett Memorial Lecture
19:20
19:20
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
19:20
AUA2023 John Duckett Memorial Lecture: Innovation by Necessity: Improving Urodynamics for Children with Spina BifidaSpeaker: Dr. Johnathan Routh, Chief of Children's Surgery, Duke University School of Medicine.Par American Urological Association
…
continue reading
1
AUA2023 John K. Lattimer Lecture
18:35
18:35
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
18:35
AUA2023 John K. Lattimer Lecture: Innovation in Urology: From a Seminal “Why” to a Functional “How”Speaker: Dr. Ralph Clayman, Distinguished Professor / Endowed Chair in Endourology, University of California, Irvine.Par American Urological Association
…
continue reading
1
Adjuvant Therapies for High-Risk Non-Metastatic Kidney Cancer
34:00
34:00
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
34:00
The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer:Adjuvant Therapies for High-Risk Non-Metastatic Kidney Cancer CME Available: https://auau.auanet.org/node/39542Release Date: December, 2023Expiration Date: December, 2024LEARNING OBJECTIVES:At the conclusion of this activity, participants will be able to:1. Identify the rationale be…
…
continue reading
1
The Latest Breakthroughs in Immunotherapy for GU Cancers
37:03
37:03
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
37:03
The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer:The Latest Breakthroughs in Immunotherapy for GU CancersCME Available: https://auau.auanet.org/node/39543Release Date: December, 2023Expiration Date: December, 2024LEARNING OBJECTIVES:At the conclusion of this activity, participants will be able to:1. Identify the newest immunothera…
…
continue reading
1
Germline Testing and Novel Approaches to Targeting Genetic Mutations in Prostate Cancer
37:22
37:22
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
37:22
The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer:Germline Testing and Novel Approaches to Targeting Genetic Mutations in Prostate Cancer CME Available: auau.auanet.org/node/39487Release Date: December, 2023Expiration Date: December, 2024LEARNING OBJECTIVESAt the conclusion of this activity, participants will be able to:1. Identify…
…
continue reading
1
Novel Imaging for Genitourinary Cancers - Diagnostics and Theranostics
32:12
32:12
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
32:12
The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer:Novel Imaging for Genitourinary Cancers - Diagnostics and TheranosticsCME Available: https://auau.auanet.org/node/39411Release Date: December, 2023Expiration Date: December, 2024LEARNING OBJECTIVESAt the conclusion of this activity, participants will be able to:1. Review the latest …
…
continue reading
1
Early Detection of Prostate Cancer: AUA/SUO Guideline (2023)
40:24
40:24
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
40:24
The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer:Early Detection of Prostate Cancer: AUA/SUO Guideline (2023)CME Available: https://auau.auanet.org/node/39410Release Date: December, 2023Expiration Date: December, 2024LEARNING OBJECTIVESAt the conclusion of this activity, participants will be able to:1. Discuss the potential benefi…
…
continue reading
1
Treatment Paradigms for Intermediate and High-Risk Non-Muscle Invasive Bladder Cancer
40:35
40:35
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
40:35
The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer:Treatment Paradigms for Intermediate and High-Risk Non-Muscle Invasive Bladder Cancer CME Available: https://auau.auanet.org/node/39374Release Date: December, 2023Expiration Date: December, 2024LEARNING OBJECTIVES:At the conclusion of this activity, participants will be able to:1. D…
…
continue reading
1
PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test
52:47
52:47
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
52:47
PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test (2023)CME Available: https://auau.auanet.org/node/39603Release Date: December, 2023Expiration Date: December, 2024LEARNING OBJECTIVES:At the conclusion of this activity, the learner will be able to:1. Review recommended criteria for genetic testing of prostate cancer patients…
…
continue reading
1
Infectious Complications Following Prostate Biopsy
40:35
40:35
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
40:35
Infectious Complications Following Prostate Biopsy: Strategies for Reducing Infections and Reducing Health Care CostsCME Available: https://auau.auanet.org/node/39485Release Date: December, 2023Expiration Date: December, 2024LEARNING OBJECTIVESAt the conclusion of this activity, participants will be able to:1. Describe health care costs associated …
…
continue reading
1
Germline Testing in GU Cancers – How I Do It
32:14
32:14
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
32:14
The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer:Germline Testing in GU Cancers – How I Do It CME Available: https://auau.auanet.org/node/39544Release Date: December, 2023Expiration Date: December, 2024ACKNOWLEDGEMENTS:Support provided by independent educational grants from: AstraZenecaJanssen Biotech, Inc., administered by Jansse…
…
continue reading
1
Treatment Intensification for Advanced Prostate Cancer
44:01
44:01
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
44:01
The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer:Treatment Intensification for Advanced Prostate CancerCME Available: https://auau.auanet.org/node/39486Release Date: November, 2023Expiration Date: November, 2024LEARNING OBJECTIVES:At the conclusion of these activities, participants will be able to:1. Identify the latest developmen…
…
continue reading
1
PARPi: Precision Medicine in Advanced Prostate Cancer
51:40
51:40
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
51:40
PARPi: Precision Medicine in Advanced Prostate Cancer (2023)CME Available: https://auau.auanet.org/node/39597Release Date: November, 2023Expiration Date: November, 2024At the conclusion of this activity, the learner will be able to:1. Describe the mechanism of action of PARP inhibitors and the differences among drugs in this class.2. Describe the r…
…
continue reading
1
Prostate Cancer Treatment Intensification
27:03
27:03
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
27:03
Prostate Cancer Treatment IntensificationModerator: Dr. Jay D. RamanGuest: Dr. Michael S. Cookson Acknowledgement: This podcast was funded by and in collaboration with AZ. All opinions are that of the faculty and do not necessarily reflect those of AstraZeneca. Release Date: 11/8/2023Expiration Date: 11/8/2024…
…
continue reading
1
Update Series (2023) Lesson 33: A Critical Appraisal of the 2021 AUA/SUFU Guideline
32:07
32:07
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
32:07
Update Series (2023) Lesson 33: A Critical Appraisal of the 2021 AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract DysfunctionNow in its 42nd installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in u…
…
continue reading
1
Disparities in Care and Barriers to Access for Patients with Advanced Prostate Cancer
30:57
30:57
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
30:57
Disparities in Care and Barriers to Access for Patients with Advanced Prostate CancerCME Available: https://auau.auanet.org/node/39088Release Date: October, 2023Expiration Date: October, 2024At the conclusion of these activities, participants will be able to:1. Recognize current patterns of use for systemic therapies in patients with advanced prost…
…
continue reading
1
Systemic Therapies for Advanced Prostate Cancer – Short and Long-Term Side Effects
36:41
36:41
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
36:41
Systemic Therapies for Advanced Prostate Cancer – Short and Long-Term Side EffectsCME Available: https://auau.auanet.org/node/39087Release Date: October, 2023Expiration Date: October, 2024At the conclusion of these activities, participants will be able to:1. Characterize current treatment paradigm for systemic therapies in managing advanced prostat…
…
continue reading
1
Genetic Testing and Stone Disease
32:00
32:00
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
32:00
Genetic Testing and Stone DiseaseCo-host: Kyle Wood, MDPopulation analysis demonstrated that genetic conditions resulting in stone disease are magnitudes higher than those seen in clinical cohorts, suggesting underdiagnosis. Urologist play a unique role as we often times have many touch points with these patient given their presentation for stone d…
…
continue reading
1
Advances in ADT Part II: A Guide for Urologists
44:09
44:09
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
44:09
Advances in ADT Part II: A Guide for UrologistsCME Available: https://auau.auanet.org/node/39385Release Date: October, 2023Expiration Date: October, 2024LEARNING OBJECTIVESAfter participating in this educational activity, participants will be able to:1. Recognize and characterize different disease states for advance prostate cancer including M0 HSP…
…
continue reading
1
Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice
1:15:06
1:15:06
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
1:15:06
Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into PracticeCME Available: https://auau.auanet.org/node/39292Release Date: September, 2023Expiration Date: September, 2024After participating in this educational activity, participants will be able to:1. Cite recommendations within the newly amended AUA/SUO Advanced Prostate Cancer Gu…
…
continue reading
1
AUA2023 Medical Student Forum
58:36
58:36
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
58:36
AUA2023 Medical Student ForumPar American Urological Association
…
continue reading
1
AUA2023: Managing Toxicities of Checkpoint Inhibitors: A Urologist’s Guide
1:42:45
1:42:45
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
1:42:45
AUA2023: Managing Toxicities of Checkpoint Inhibitors: A Urologist’s GuideCME Available: https://auau.auanet.org/node/38322CME Expiration Date: May, 2024ACKNOWLEDGEMENTSIndependent educational grant support provided by:AstellasAstraZenecaJanssen Biotech, Inc., administered by Janssen Scientific Affairs, LLCLantheus Medical ImagingMerck & Co., Inc.P…
…
continue reading
1
AUA2023: How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients
1:59:12
1:59:12
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
1:59:12
AUA2023: How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients following Local Therapy with Curative Intent CME Available: https://auau.auanet.org/node/38312CME Expiration Date: May, 2024ACKNOWLEDGEMENTSIndependent educational grant support provided by:AstellasAstraZenecaJanssen Biotech, Inc., administered by Janssen Scient…
…
continue reading
1
Treatment for Hormone Sensitive Prostate Cancer
49:01
49:01
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
49:01
Treatment for Hormone Sensitive Prostate CancerCME Available: https://auau.auanet.org/node/38703Treatment for Hormone Sensitive Prostate Cancer (2023), is an exciting new educational offering to update urologists on the latest advancements in the management of hormone sensitive prostate cancer (HSPC), including treatment intensification. This educa…
…
continue reading
1
Update Series (2023) Lesson 21: Management of Chronic Pelvic Pain in Men
25:05
25:05
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
25:05
Update Series (2023) Lesson 21: Management of Chronic Pelvic Pain in MenNow in its 42nd installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and …
…
continue reading
1
AUA2023: Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider
1:57:38
1:57:38
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
1:57:38
AUA2023: Chemotherapy and Immunotherapy for the Urologist and Advanced Practice ProviderCME Available: https://auau.auanet.org/node/38307CME Expiration Date: May, 2024ACKNOWLEDGEMENTSIndependent educational grant support provided by:AstellasAstraZenecaJanssen Biotech, Inc., administered by Janssen Scientific Affairs, LLCLantheus Medical ImagingMerc…
…
continue reading
1
AUA2023: Upper-Tract Urothelial Cancer Guidelines
2:02:09
2:02:09
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
2:02:09
AUA2023: Upper-Tract Urothelial Cancer Guidelines: An Interactive and Evidence-based Course Highlighting the Full Spectrum of Disease via Case Discussion and Video PresentationCME Available: https://auau.auanet.org/node/38327CME Expiration Date: May, 2024ACKNOWLEDGEMENTSIndependent educational grant support provided by:AstraZenecaMerck & Co., Inc.P…
…
continue reading
1
AUA2023: What the General Urologist Should Know about Care of Transgender Patients
1:52:16
1:52:16
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
1:52:16
AUA2023: What the General Urologist Should Know about Care of Transgender PatientsCME Available: https://auau.auanet.org/node/38342CME Expiration Date: May, 2024ACKNOWLEDGEMENTSIndependent educational grant support provided by:AstraZenecaJanssen Biotech, Inc., administered by Janssen Scientific Affairs, LLCMerck & Co., Inc.…
…
continue reading
1
AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes
1:54:24
1:54:24
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
1:54:24
AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize OutcomesCME Available: https://auau.auanet.org/node/38287CME Expiration Date: May, 2024ACKNOWLEDGEMENTSIndependent educational grant support provided by:AstellasUrovant Sciences, Inc.Par American Urological Association
…
continue reading
1
AUA2023: Prostate Cancer Diagnosis
1:49:34
1:49:34
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
1:49:34
AUA2023: Prostate Cancer DiagnosisCME Available: https://auau.auanet.org/node/38302CME Expiration Date: May, 2024ACKNOWLEDGEMENTSIndependent educational grant support provided by:AstellasAstraZenecaJanssen Biotech, Inc., administered by Janssen Scientific Affairs, LLCLantheus Medical ImagingMerck & Co., Inc.Pfizer, Inc.…
…
continue reading